The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
activistletters

Brookdale Senior Living (BKD) Faces Ortelius’ Push for Accountability Amid Underperformance and Leadership Concerns

Summary

The Ortelius Advisors filing (June 3, 2025) relates to its proxy fight at Brookdale Senior Living. While the full presentation text is sparse in the extract, Ortelius has been pressing for board change, arguing Brookdale has suffered from prolonged underperformance, poor capital allocation, and weak governance. Its campaign centers on nominating directors it claims will bring accountability, operational expertise, and a focus on unlocking value for shareholders. This June filing represents the continuation of its solicitation efforts, urging shareholders to back its nominees on the proxy card.

Company Name: Brookdale Senior Living Inc.
Symbol: BKD
Filing Date: Jun-03-2025
Filer Name: Ortelius Advisors, L.P.

Download Presentation
Ortelius-Brookdale-Jun-03-2025.pdf
14 MB
download-circle

Source:

https://www.sec.gov/Archives/edgar/data/1332349/000092189525001684/ex1todfan14a11126009_060325.pdf

Member discussion

More like this

STAAR Surgical (STAA): Broadwood Partners Urges Shareholders to Reject Alcon Merger Over Governance and Valuation Concerns

Summary Broadwood Partners’ presentation argues that STAAR Surgical’s sale to Alcon is ill-timed, flawed, and undervalued. It claims STAAR’

Khrom Capital Pushes Acadia Healthcare (ACHC) Board to Pursue Sale, Slams Entrenched Leadership and Poor Capital Allocation

Summary Khrom Capital, owning 5.5% of Acadia Healthcare, criticized the company’s decade-long underperformance, poor capital allocation, and entrenched

STAAR Surgical (STAA): Broadwood Capital Urges Shareholders to Reject Alcon Merger, Highlighting Governance Conflicts and Poor Timing

Summary Broadwood Capital, owning 27.5% of STAAR Surgical, urged shareholders to vote against the proposed $28-per-share sale to Alcon,

Al Hartman Presses Silver Star Properties REIT (SLVS) Holders: Reject Current Board, Back Liquidation Plan Amid Alleged Misconduct and Value Destruction

Summary Al Hartman’s Hartman Shareholder Alliance urges Silver Star investors to vote the BLUE proxy as a “last chance”

Broadwood Partners Challenges STAAR Surgical (STAA) Sale to Alcon, Citing Inopportune Timing, Governance Issues, and Undervaluation

Summary Broadwood Partners, STAAR Surgical’s largest shareholder with a 27.5% stake, urged stockholders to vote against the proposed

Yunqi Capital Challenges STAAR Surgical (STAA)–Alcon Deal, Citing Undervaluation, Weak China Outlook Assumptions, and Governance Failures

Summary Yunqi Capital, a 5.1% shareholder of STAAR Surgical, announced it will vote against the company’s proposed $28